Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004136200 on September 14, 2000

J. Biol. Chem., Vol. 275, Issue 49, 38268-38274, December 8, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/49/38268    most recent
M004136200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Costa, E. T.
Right arrow Articles by Valenzuela, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Costa, E. T.
Right arrow Articles by Valenzuela, C. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Fetal Alcohol Exposure Alters Neurosteroid Modulation of Hippocampal N-Methyl-D-aspartate Receptors*

Edmar T. Costa, Dorian S. Olivera, Douglas A. Meyer, Vania M. M. Ferreira, Eli E. Soto, Shanti Frausto, Daniel D. Savage, Michael D. BrowningDagger , and C. Fernando Valenzuela§

From the Department of Neurosciences, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131-5223 and Dagger  Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado 80262

Received for publication, May 15, 2000, and in revised form, August 23, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The actions of ethanol on brain ligand-gated ion channels have important roles in the pathophysiology of alcohol-related neurodevelopmental disorders and fetal alcohol syndrome. Studies have shown that N-methyl-D-aspartate (NMDA) receptors are among the ligand-gated ion channels affected by prenatal ethanol exposure. We exposed pregnant dams to an ethanol-containing liquid diet that results in blood ethanol levels near the legal intoxication limit in most states (0.08%). Primary cultures of hippocampal neurons were prepared from the neonatal offspring of these dams, and NMDA receptor function was assessed by patch clamp electrophysiological techniques after 6-7 days in culture in ethanol-free media. Unexpectedly, we did not detect any changes in hippocampal NMDA receptor function at either the whole-cell or single-channel levels. However, we determined that fetal alcohol exposure alters the actions of the neurosteroids pregnenolone sulfate and pregnenolone hemisuccinate, which potentiate NMDA receptor function. Western immunoblot analyses demonstrated that this alteration is not due to a change in the expression levels of NMDA receptor subunits. Importantly, in utero ethanol exposure did not affect the actions of neurosteroids that inhibit NMDA receptor function. Moreover, the actions of pregnenolone sulfate on type A gamma -aminobutyric acid and non-NMDA receptor function were unaltered by ethanol exposure in utero, which suggests that the alteration is specific to NMDA receptors. These findings are significant because they provide, at least in part, a plausible mechanistic explanation for the alterations in the behavioral responses to neurosteroids found in neonatal rats prenatally exposed to ethanol and to other forms of maternal stress (Zimmerberg, B., and McDonald, B. C. (1996) Pharmacol. Biochem. Behav. 55, 541-547).



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ingestion of ethanol during pregnancy can have profound effects on normal fetal development. These effects range from isolated alcohol-related birth defects to a combination of abnormalities that characterize the fetal alcohol syndrome (1). This syndrome is characterized by alterations in growth, facial and skull development, and central nervous system function. Fetal ethanol exposure produces long-lasting and debilitating neurobehavioral and neurophysiological dysfunctions such as deficits in learning, memory, information processing, and problem solving skills (2-5). Therefore, there is considerable interest in understanding the consequences of the teratogenic actions of ethanol in the central nervous system.

Research from a number of laboratories suggests that the actions of ethanol on ligand-gated ion channels have important roles in the pathophysiology of alcohol-related neurodevelopmental disorders (for review, see Ref. 6). Experimental evidence indicates that glutamate receptors of the N-methyl-D-aspartate (NMDA)1 subtype are among the ligand-gated ion channels affected by fetal exposure to ethanol. Studies have shown that fetal and/or neonatal ethanol exposure alters ligand binding to NMDA receptors and expression of NMDA receptor subunits (7-11). Reductions in NMDA receptor function have also been detected in neuronal preparations from both the neonatal and the adult offspring of rats exposed to ethanol during pregnancy (6, 12-15). Since the normal functioning of NMDA receptors is critical for growth, proliferation, differentiation, migration, plasticity, and programmed death of neurons (16-23), the effects of ethanol on fetal NMDA receptors could seriously affect normal neurodevelopment and have long-lasting consequences later in life.

The participation of the NMDA-Rs in complex neurodevelopmental and neurobehavioral processes requires precise regulation of the function of these channels. Among the molecules that regulate NMDA receptors are the neurosteroids, which produce rapid effects on the function of these receptors by nongenomic mechanisms. Compounds such as dehydroepiandrosterone and pregnenolone sulfate (PS) enhance NMDA-R function (24-28). This neurosteroid-mediated enhancement of NMDA-R function was shown to have a role in axonal elongation in developing neurons (25). Dehydroepiandrosterone and PS were also shown to enhance cognitive performance and to have anxiogenic effects in rodents (29-32). Importantly, Zimmerberg and collaborators found that prenatal ethanol exposure reduced the anxiogenic effect of PS in neonates subjected to maternal separation-induced stress (33). The authors of this study postulated that alterations in the sensitivity of ligand-gated ion channels to neurosteroids could mediate these effects of prenatal ethanol exposure. It is noteworthy, however, that the mechanism by which prenatal alcohol exposure produces these alterations in the behavioral responses to neurosteroids has yet to be determined.

We have investigated the effects of fetal ethanol exposure on NMDA-R function and modulation by neurosteroids. Rats consumed a liquid diet that produces blood ethanol levels of ~0.08%, which are near the legal intoxication limit in many states. We then prepared primary cultures of hippocampal neurons from the offspring of these rats and used patch clamp electrophysiological techniques to assess NMDA-R function after 6-7 days in culture. We found that exposure to ethanol during pregnancy affects the sensitivity of NMDA-Rs to neurosteroids.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ethanol Liquid Diet Paradigm

Details of the breeding colony procedures have been described previously (34). Five-month-old Harlan Sprague-Dawley rat dams (Harlan Industries, Indianapolis, IN) were individually housed in plastic cages in a temperature-controlled room (22 °C) on a 16-h dark:8-h light schedule (lights off from 5:30 p.m. to 9:30 a.m.). Beginning on day 1 of gestation, rat dams were assigned to one of the three diet groups. Two of the three diets consisted of a liquid diet based on the Lieber-DeCarli (35) formulation, which provides 1 kcal/ml (BioServ, Frenchtown, NJ). These groups received 110 ml of liquid diet at 5:30 p.m. each day. The feeding tubes were removed 16 h later (at 9:30 a.m. on the next morning). The fetal ethanol-exposed group received a liquid diet containing no ethanol for the first 2 days of gestation for adjustment to the liquid diet. The animals in this group were then given 110 ml of a liquid diet containing 2% (v/v) ethanol for the gestational days 3-4, 3% (v/v) for the next 2 days, and thereafter 5% (v/v) ethanol (26% ethanol-derived calories) until they gave birth. This diet produces blood alcohol levels of ~0.08% (34). The other liquid diet group, serving as pair-fed control, was given a 0% ethanol liquid diet (isocalorically equivalent to the 5% ethanol diet) each day throughout the gestation. A third diet group had continuous access to Purina breeder block chow and water ad libitum and served as control for the paired feeding technique. At birth, all litters were weighed and counted.

Primary Cultures of Hippocampal Neurons

Cultures were prepared from 3-4-day-old rats. Meninge-free hippocampi were microdissected in cold sterile phosphate-buffered saline plus 15 mM HEPES, 27 mM glucose, 17.5 mM sucrose, pH 7.4, with a final osmolarity of 320-335 mosmol. Isolated hippocampi were incubated for 10 min at 37 °C in 0.05% trypsin-EDTA (Life Technologies, Inc.), transferred to neurobasal A media (Life Technologies, Inc.) containing 10% fetal bovine serum, and then gently triturated with a Pasteur pipette. Trituration was repeated with a Pasteur pipette flamed to half its original opening size. Cells were then plated at a density of 15-20 × 103/ml of media in culture dishes containing coverslips coated with polylysine and collagen and maintained at 37 °C with 5% CO2 in a humidified atmosphere. Cells were initially plated in neurobasal A media (Life Technologies, Inc.) containing 10% fetal bovine serum, 100 units/ml penicillin, 0.1 mg/ml streptomycin, and 25 µM glutamate. After 24 h, fetal bovine serum was substituted with the B27 supplement (Life Technologies, Inc.) and after 3 days in culture, glutamate was removed from the culture media. Cells were used for experiments after 6-7 days in culture. Neurons used for recordings were large and had pyramidal shape and well defined dendritic processes.

Patch Clamp Electrophysiological Recordings

Whole-cell Configuration-- Immediately before recording, coverslips were transferred to a perfusion chamber (Warner Instruments, Hampden, CT), and neurons were visualized under a Zeiss inverted microscope equipped with Varel contrast optics or under an Olympus microscope equipped with Hoffman modulation optics. Membrane potentials were clamped at -60 mV with an Axopatch 200B amplifier (Axon Instruments, Foster City, CA). The resting membrane potential for the recorded neurons was approximately -60 mV. Recording pipettes (borosilicate capillaries with filament, outer diameter 1.5 mm, Sutter Instruments, Novato, CA) were prepared with a two-step puller (Narishige Instrument Co, Tokyo, Japan) and had resistances between 5-9 megaohms. Series resistance was not compensated. The external solution (all chemicals from Sigma) contained 130 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, pH 7.3, 11 mM glucose, and 300 nM tetrodotoxin. For NMDA recordings, this solution was nominally Mg2+-free. The internal solution contained (all chemicals from Fluka, Milwaukee, WI) 130 mM KCl, 10 mM HEPES, 0.1 mM CaCl2, 1 mM EGTA, 2 mM ATP, and 0.2 mM GTP. For recordings of kainate and GABAA receptor-mediated currents, glass microelectrodes were front-filled with internal solution containing (all chemicals were from Fluka) 155 mM KCl, 10 mM HEPES, pH 7.3, 5 mM EGTA, and 1 mM MgCl2 adjusted to 285 mosmol. Pipettes were then back-filled with the same internal solution containing 50 units/ml creatinine phosphokinase, 22 mM phosphocreatine, and 4 mM Mg2+-ATP (300 mosmol). Drugs were applied with a fast-exchange flow-tube perfusion system driven by motor (Warner Instrument Co.). Agonists were applied at 30-60-s intervals. The neurosteroids, PS (5-pregnen-3beta -ol-20-one sulfate), pregnenolone hemisuccinate (PHS; 5-pregnen-3beta -ol-20-one hemisuccinate), 5beta -pregnan-3alpha -ol-20-one sulfate(3alpha 5beta PS), and 5beta -pregnan-3alpha -ol-20-one hemisuccinate (3alpha 5beta PHS), were obtained from Steraloids Inc. (Newport, RI). Steroid solutions were prepared as 100-250 mM stocks in Me2SO. The final Me2SO concentration of all recording solutions was between 0.01% and 0.05%. Identical concentrations of Me2SO were added to control solutions. All experiments were performed at room temperature (23-25 °C).

Data were acquired and analyzed with either the Neuropro software (RC Electronics, Santa Barbara, CA) or pClamp7 (Axon Instruments). Modulation of NMDA, kainate, and GABAA responses by neurosteroids is presented as percent change, [(I'/I- 1] × 100%, where I is the average of control responses obtained before application and after washout of steroid, and I' is the average of agonist-induced responses obtained from the same cell in the presence of steroid.

Single-channel Measurements-- Single-channel recordings were obtained in the cell-attached configuration to avoid alterations in intracellular modulators of NMDA-R function. The patch solution contained 10 µM NMDA and 1 µM glycine in a solution containing 70 mM NaCl, 70 mM Na2SO4, 10 mM HEPES, 1.2 mM CaCl2, 5 mM Cs2SO4, 33 mM glucose, pH 7.4, and 300 mosmol. The pipette potential was +20 mV. Events were recorded with an Axopatch 200B amplifier (Axon Instruments) and stored on digital tape using a digital audio tape recorder (Panasonic SV3800). Pipettes were pulled from borosilicate glass, lightly fire-polished, and coated with Sylgard (Dow Corning, MI). Recordings were played back and acquired and analyzed using the pClamp7 program (Axon Instruments). Single-channel currents were initially filtered at 2 kHz and sampled at 5 kHz. Only patches with stable basal activities were used. The single channel open probability was determined from the ratio of the time spent in the open state to the duration of recording: Po = (t1 + t2 +  ... + tn)/Nttot, where t is the amount of time that n channels are open, and N is the maximum number of levels observed in the recording. Open times were obtained with the pStat 6.0 computer program (Axon Instruments) by fitting plots of event number versus open time to exponential functions using the Marquardt algorithm. Closed times were obtained in the same manner from plots of event number versus log of closed time.

Western Immunoblots

Hippocampi from two P3 neonates, each from 3-6 different litters per diet group, were homogenized by sonication and analyzed by SDS-polyacrylamide gel electrophoresis and Western immunoblot assays. Anti-NR2A, -2B, -2C, NR1-N1, NR1-C1, and NR1-C2 antibodies were produced, purified, and characterized in the laboratory of Dr. Browning at the University of Colorado Health Sciences Center. Anti-NR1 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Detection of bound antibodies was performed by chemiluminescence using a kit from Roche Molecular Biochemicals. Densitometric analysis of Western blot chemiluminescence x-ray films were performed using an Image-Pro® Plus image analysis system (Media Cybernetics, Silver Spring, MD). In all cases, a protein standard curve was generated from a single homogenate of adult rat hippocampal tissue kept at -80 °C. This standard curve was included in the same membrane (using 15-well combs) as samples from control and ethanol-treated animals. This curve was used to calculate relative units of protein concentrations. We selected the appropriate bands and measured relative optical density with respect to these standards. To correct for variations in protein loading, concentrations of all samples were normalized against beta -tubulin levels (anti-beta -tubulin monoclonal antibody was from Sigma). Relative protein concentrations are expressed as relative units (R.U.) of protein/R.U. of tubulin.

Statistical Analysis

The potentiating or inhibiting effects of neurosteroids were quantified with respect to the average of control and washout responses. Neurosteroid dose response curves were fitted to four-parameter logistic equations (sigmoid) using GraphPad Prizm computer program (San Diego, CA). Statistical comparison of the effect of neurosteroids among the three diet groups was performed by ANOVA followed by Bonferroni's post hoc test. Effect of multiple concentrations of PS on neurons from all three diet groups were analyzed by two-way ANOVA. Effects of PS on non-NMDA and GABAA receptor function in cells from the pair-fed versus fetal ethanol-exposed groups were analyzed by t test. In all cases, a p < 0.05 was considered to indicate statistical significance.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Fetal Ethanol Exposure Paradigm-- Table I summarizes the results of the feeding paradigm used in this study (values are mean ± S.E. of 34-43 dams/diet group). No statistical differences were found in diet consumption, total number of newborns, live newborns, or the average mean weight of live newborns among the three diet groups. Furthermore, no gross anatomical abnormalities were noted at birth in the fetal ethanol-exposed animals.


                              
View this table:
[in this window]
[in a new window]
 
Table I
Comparison of liquid diet consumption and the effects of diets on offspring at birth
Values are mean ± S.E. of 36, 43, and 40 dams for the ad libitum, pair-fed, and fetal ethanol groups, respectively.

Effects of Prenatal Ethanol Exposure on Basic NMDA-R Function-- Shown in Fig. 1 are NMDA dose response curves recorded in the whole-cell patch clamp configuration for neurons from the ad libitum control, pair-fed control, and fetal ethanol-exposed groups. Fig. 1A shows examples of currents obtained by increasing concentrations of NMDA in the presence of a constant glycine (1 µM) concentration. Fig. 1B shows a summary graph of NMDA dose response curves obtained from neurons from the three feeding groups (n = 6-9 neurons from 2-3 different litters per diet group). Data were normalized with respect to maximum NMDA (100 µM) currents. The EC50 concentrations were 11 ± 1, 12 ± 1, and 13 ± 1 µM for neurons from the ad libitum control, pair-fed control, and the fetal ethanol-exposed groups, respectively. The Hill slope was ~1.4 for all treatment groups. It should be noted that we did not find a difference in NMDA-R maximum current densities (pA/picofarads) (Fig. 1B, inset). Current densities were 11 ± 1, 11 ± 1, and 13 ± 1 pA/picofarads for neurons from the ad libitum control, pair-fed control, and the fetal ethanol-exposed groups, respectively (n = 21-23 neurons from 3-4 different litters per diet group).



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1.   NMDA dose response curves recorded in the whole-cell patch clamp configuration from cultured hippocampal neurons. A, sample currents from ad libitum control and fetal ethanol-exposed groups obtained by increasing concentrations of NMDA in presence of a constant glycine (1 µM) concentration (scale bar represents 100 pA and 200 ms). B, summary graph of NMDA dose response curves obtained from all three feeding groups (n = 6-9 neurons from 2-3 different litters per group). Data were normalized with respect to maximum NMDA (100 µM) currents. The inset in panel B shows the NMDA receptor maximum current densities (pA/picofarads) for neurons from the ad libitum control, pair-fed control, and the fetal ethanol-exposed groups, respectively (n = 21-23 neurons from 3-4 different litters per group). C, summary graph of 7-chlorokynurenate (7-CKA) competition curves obtained from all three feeding groups (n = 4-5 neurons from 2-3 different litters per group) in the presence of a constant concentration of NMDA (100 µM) and glycine (1 µM).

We also measured dose response curves for 7-chlorokynurenate, a competitive antagonist of the glycine co-agonist site of NMDA-Rs (Fig. 1C), in the presence of constant NMDA (100 µM) plus glycine (1 µM) concentrations (n = 4-5 neurons from 2-3 litters per diet group). The IC50 concentrations were 83 ± 18, 57 ± 17, and 93 ± 29 nM for neurons from the ad libitum control, pair-fed control, and the fetal ethanol-exposed groups, respectively. Statistical analysis did not reveal significant differences among these diet groups.

We also assessed the effect of fetal ethanol exposure on NMDA-R function at the single channel level. Fig. 2 shows sample tracings obtained from neurons from pair-fed and fetal ethanol-exposed groups in the cell-attached configuration. The patch solution contained 10 µM NMDA and 1 µM glycine. Single channel parameters are summarized in Table II. We did not detect any statistically significant differences in any of these parameters among the three diet groups. Since resting membrane potentials cannot be determined in the cell-attached mode, single-channel conductance was not calculated.



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Sample tracings from cell-attached single-channel recordings obtained from neurons from pair-fed and fetal ethanol-exposed neonatal rats. The patch solution contained 10 µM NMDA and 1 µM glycine. The pipette potential was +20 mV. Single channel parameters are summarized in Table II. Scale represents 10 pA and 40 ms.


                              
View this table:
[in this window]
[in a new window]
 
Table II
NMDA receptors single-channel parameters (cell-attached mode)
Values are mean ± S.E.

Positive Modulation of NMDA-R by Neurosteroids-- Sample tracings illustrating the effects of 50 µM PS on currents induced by application of 50 µM NMDA on cultured hippocampal neurons from ad libitum, pair-fed, and fetal ethanol-exposed neonatal rats are shown in Fig. 3A. PS produced a significant potentiation of NMDA-R-mediated currents in cells from the ad libitum and the pair-fed groups but not in cells from the fetal ethanol-exposed group (Table III). The reduction in the effects of PS was evident at different concentrations of this neurosteroid (Fig. 3B).



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 3.   Fetal alcohol exposure affects modulation of NMDA-R by PS. A, sample tracings showing the effect of 50 µM PS on currents gated by 50 µM NMDA in cultured hippocampal neurons from ad libitum control, pair-fed control, and fetal ethanol-exposed neonatal rats (scale bar is 100 pA and 200 ms). B, prenatal ethanol exposure significantly (p < 0.02 by two-way ANOVA) reduces the action of different concentrations of PS on currents gated by 50 µM NMDA in neurons from the fetal ethanol-exposed group (for each point, n = 4-7 neurons from 2-8 different litters per group).


                              
View this table:
[in this window]
[in a new window]
 
Table III
Effect of fetal ethanol exposure on modulation of ligand-gated ion channel currents by PS (50 µM)
Values are mean ± S.E. Numbers of neurons tested are given in parentheses. Neurons were obtained from 5-8 different litters per diet group for NMDA experiments and from one litter per diet group for the non-NMDA and GABAA experiments.

Shown in Fig. 4A are sample traces illustrating the effect of PHS on NMDA-R-mediated currents in all the three diet groups. In neurons from ad libitum controls, pair-fed controls, and fetal ethanol-exposed rats, the amplitude of these currents in the presence of 50 µM PHS corresponded to 53 ± 9% (n = 6 neurons from 3 different litters), 55 ± 13% (n = 6 neurons from 3 different litters), and 17 ± 8% (n = 8 neurons from 2 different litters) of control, respectively (Fig. 4B).



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Fetal alcohol exposure affects modulation of NMDA-R by PHS. A, sample tracings showing the effect of 50 µM PHS on currents gated by 50 µM NMDA in cultured hippocampal neurons from ad libitum control, pair-fed control, and fetal ethanol-exposed neonatal rats (scale bar is 100 pA and 200 ms). B, summary of the effect of 50 µM PHS in the three diet groups (for each point, n = 6-8 neurons from 2-3 different litters per group; *, p < 0.02 by one-way ANOVA followed by Bonferroni's post hoc test).

Statistical analysis indicated that the effect of both PS and PHS was significantly different in neurons from ethanol-exposed rats versus ad libitum and pair-fed controls (p < 0.02 by ANOVA followed by Bonferroni's test). The results of these experiments suggest that modulation of NMDA-Rs by neurosteroids that potentiate receptor function is impaired by prenatal ethanol exposure.

Modulation of NMDA-R by Negative Modulating Neurosteroids-- Shown in Fig. 5A are sample tracings illustrating the effect of 3alpha 5beta PS, a negative neurosteroid modulator of NMDA-Rs. In neurons from ad libitum control, pair-fed controls and fetal ethanol-exposed rats, the amplitude of these currents in the presence of 100 µM 3alpha 5beta PS was decreased by 52 ± 12% (n = 9 neurons from 1 litter), 44 ± 15% (n = 7 neurons from 2 different litters), and 40 ± 4% (n = 6 neurons from 2 different litters) in comparison to control, respectively (Fig. 5B). The amplitude of NMDA-R currents in neurons from the same diet groups in the presence of 100 µM 3alpha 5beta PHS were decreased to 60 ± 23% (n = 9 neurons from 2 different litters), 78 ± 17% (n = 7 neurons from 3 different litters), and 73 ± 23% (n = 7 neurons from 3 different litters) of control values (Fig. 5C). Statistical analysis indicated that the effect of both 3alpha 5beta PS and 3alpha 5beta PHS was not significantly different in neurons from ethanol-exposed rats versus ad libitum and pair-fed controls (p > 0.05 by ANOVA followed by Bonferroni's test).



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 5.   Actions of negative modulating neurosteroids 3alpha 5beta PS and 3alpha 5beta PHS are unaffected by fetal ethanol exposure. A, sample tracings showing the effect of 100 µM 3alpha 5beta PS on currents gated by 50 µM NMDA in cultured hippocampal neurons from ad libitum control, pair-fed control, and fetal ethanol-exposed rats (scale bar is 100 pA and 200 ms). B, summary of the effect of 100 µM 3alpha 5beta PS (n = 6-7 neurons from 1-2 different litters per group). C, summary of the effect of 100 µM 3alpha 5beta PHS (n = 7-9 neurons from 2-3 different litters per group).

Modulation of Non-NMDA and GABAA Receptors by Neurosteroids-- PS has been shown to selectively modulate other classes of ionotropic receptors. PS inhibits AMPA/kainate and GABAA receptors (27, 36, 37). Thus, we performed experiments to investigate possible alterations in the neurosteroid modulation on the function of these receptors in neurons from animals prenatally exposed to ethanol. In neurons from the pair-fed control and fetal ethanol-exposed rats, application of 50 µM PS inhibited to the same extent currents elicited by 100 µM kainate (Table III). 50 µM PS also inhibited by the same magnitude currents gated by 50 µM GABA (Table III) in neurons from the pair-fed control and fetal ethanol-exposed neonatal rats. Statistical analysis (t test) indicated that the effect of PS was not significantly different in neurons from ethanol-exposed rats versus pair-fed controls (Table III).

Expression Levels of NMDA Receptor Subunits-- Fig. 6 shows examples of Western immunoblot analyses of NMDA receptor subunit expression in hippocampal homogenates from P3 neonates from the ad libitum, pair-fed and fetal ethanol groups. These examples illustrate that the levels of these subunits are not affected by fetal ethanol exposure. NR2A subunit levels were 0.46 ± 0.13, 0.39 ± 0.09, and 0.28 ± 0.13 R.U. of protein/R.U. of tubulin, respectively (n = 3 homogenates, each from a different litter). NR2B subunit levels were 0.34 ± 0.06, 0.37 ± 0.10, and 0.38 ± 0.05 R.U. of protein/R.U. of tubulin, respectively (n = 6 homogenates, each from a different litter). NR2C subunit levels were 0.27 ± 0.02, 0.29 ± 0.03, and 0.29 ± 0.03 R.U. of protein/R.U. of tubulin, respectively (n = 6 homogenates, each from a different litter). NR1 subunit levels were 0.76 ± 0.12, 1.1 ± 0.22, and 0.92 ± 0.14 R.U. of protein/R.U. of tubulin, respectively (n = 6 homogenates, each from a different litter). Levels of NR1 subunits containing the N1 cassette (NR1-N1) were 1.04 ± 0.15, 1.03 ± 0.18, and 0.86 ± 0.13 R.U. of protein/R.U. of tubulin, respectively (n = 5 homogenates, each from a different litter). Levels of NR1 subunits containing the C2 cassette (NR1-C2) were 0.61 ± 0.08, 0.71 ± 0.11, and 0.65 ± 0.03 R.U. of protein/R.U. of tubulin (n = 5 homogenates, each from a different litter). Expression of NR1 subunits containing the C1 cassette (NR1-C1) was not detected (n = 6 homogenates, each from a different litter).



View larger version (61K):
[in this window]
[in a new window]
 
Fig. 6.   Expression of NMDA-R subunits in hippocampal homogenates from neonates belonging to the ad libitum, pair-fed, and fetal ethanol-exposed groups. Shown are examples of Western immunoblots for the indicated NMDA-R subunits, including NR1 subunits containing the N1, C1, and C2 cassettes. Also shown are samples of immunoblots for beta -tubulin, which were used to correct for variations in protein loading. Each of the bands shown per group is from a homogenate prepared from the hippocampi of two neonates (P3-4). Each homogenate was obtained from animals belonging to different litters. Shown on the left are protein standard curves generated from a single homogenate of adult rat hippocampal tissue of known protein concentration. The protein amounts loaded per standard curve lane were 5, 10, 15, and 20 µg. This curve was used to calculate relative units of protein concentrations. Note the expression of NR1-C1 subunits in the adult homogenates but not in the neonatal homogenates. See text for details on the methodology and the results of densitometric analyses.



    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Contrary to expectations, we found that the basic parameters of NMDA-R function were unaffected by our fetal ethanol exposure paradigm. We expected to detect alterations in NMDA-R function because a number of studies have consistently found reductions in NMDA-R-mediated responses in neurons from the offspring of ethanol-exposed dams. One of these studies showed that exposure of pregnant rats to blood alcohol levels of ~0.04% resulted in a long term reduction of NMDA-dependent responses in CA1 hippocampal pyramidal neurons in slices from the adult offspring of these rats (38). Studies using dispersed neurons have also demonstrated prenatal ethanol exposure-induced reductions in NMDA-R function. Fetal ethanol exposure to blood alcohol levels ranging between 0.03 and 0.15% was shown to reduce NMDA receptor-mediated increases in intracellular Ca2+ levels in acutely dissociated neurons from either the whole brain (12, 13) or specific central nervous system regions such as the hippocampus, forebrain, and cerebellum of newborn rats (14). In contrast to these studies, we did not detect any changes in hippocampal NMDA-R function at neither the whole-cell or single-channel levels (Figs. 1 and 2). There are multiple factors that could account for the differences between our results and those of the Ca2+-imaging studies discussed above. First, it must be considered that, for some of those studies (13, 14), pregnant rats were exposed to higher blood alcohol levels (0.12-0.15%) than those that are achieved with our diet (~0.08%) (34). Second, for the Ca2+-imaging studies, NMDA-R function was assessed in neurons acutely dissociated from newborn rats within 24 h after birth; i.e. during the immediate period of withdrawal from in utero ethanol exposure (12-14). In contrast, we measured NMDA receptor function in hippocampal neuronal cultures prepared 3-4 days after withdrawal from fetal ethanol exposure, and we performed electrophysiological recordings after culturing these neurons for an additional 6-7 days in ethanol-free media. Finally, it must be kept in mind that Ca2+-imaging techniques do not directly assess NMDA-R function but measure the change in intracellular Ca2+ levels in response to NMDA-R activation. NMDA-R-induced changes in intracellular Ca2+ levels have been shown to be complex, involving, for example, the release of Ca2+ from intracellular stores (39) and the activation of voltage-gated Ca2+ channels (40). Thus, the findings of these Ca2+-imaging studies must be interpreted cautiously considering that prenatal ethanol exposure could have affected NMDA-R-dependent Ca2+ elevations at a point downstream of the NMDA-R itself. Despite these technical differences between studies, it should be emphasized that an important conclusion of our study is that prenatal ethanol exposure may not produce long-lasting changes in hippocampal NMDA-R function in all cases.

A positive finding of our study was that prenatal ethanol exposure affects the sensitivity of NMDA-R to neurosteroids (Figs. 3 and 4 and Table III). In agreement with previous reports (26-28, 41), we found that both PS and PHS produced significant potentiation of NMDA-R-mediated whole-cell currents in cultured hippocampal neurons from control rats. In contrast, the NMDA-R potentiating actions of these neurosteroids were significantly reduced in neurons obtained from neonates prenatally exposed to ethanol. Interestingly, the actions of neurosteroids that inhibit NMDA-R function, such as 3alpha 5beta PS and 3alpha 5beta PHS, were not significantly affected by prenatal ethanol exposure (Fig. 5). Based on competition studies, Park-Chung et al. (26) determined that positive and negative neurosteroid modulators of NMDA-R function act at specific, extracellularly directed sites that are distinct from one another. Thus, prenatal ethanol exposure appears to selectively affect the site of action of positive neurosteroid modulators of NMDA-Rs. The mechanism underlying this selective effect of prenatal ethanol exposure is unclear at the present time because the mechanism of the modulatory actions of neurosteroids on NMDA-R has yet to be determined. It is noteworthy, however, that studies with recombinant receptors suggest that subunit composition is an important determinant of the sensitivity of the NMDA-R to neurosteroids (28). However, we did not detect any changes in the expression levels of NMDA-R subunits in hippocampal homogenates from fetal ethanol-exposed neonates. Consequently, another mechanism must underlie this decrease in sensitivity of NMDA-Rs to positive neurosteroid modulators. A possible mechanism could involve alterations in NMDA-R phosphorylation. Although the role of phosphorylation on neurosteroid actions on NMDA-R has not been studied, changes in protein phosphorylation do regulate the sensitivity to neurosteroids of voltage-gated Ca2+ channels (42) and GABAA receptors (43). Therefore, it is possible that the mechanism of action of prenatal ethanol exposure involves a change in the phosphorylation state of the NMDA-R, and we are currently examining this possibility experimentally.

It should be noted that prenatal ethanol exposure was recently shown to alter modulation of another ligand-gated ion channel by neurosteroids. Allan et al. (34) report that neurosteroid modulation of GABAA receptors is altered in the adult offspring of dams exposed to a diet of identical composition to the one used in our study. Prenatal ethanol exposure induced a reduction in the modulatory effects of alphaxalone and PS on GABA-stimulated 36Cl- flux into membrane vesicles prepared from the medial frontal cortex (34). In hippocampal membrane vesicles, prenatal ethanol exposure did not change the effects of PS but enhanced the positive modulatory effects of alphaxalone (34). The results of these experiments with hippocampal microsacs are consistent with our finding that the inhibitory effect of PS on GABAA receptors is unaltered in cultured hippocampal neurons from the fetal ethanol-exposed group. Thus, prenatal ethanol exposure appears to selectively target neurosteroid modulation of NMDA receptors in the hippocampus. Our finding that fetal ethanol exposure did not alter neurosteroid modulation of kainate-induced currents in hippocampal neurons further supports this conclusion.

The findings of the present study are significant because they provide, at least in part, a plausible mechanistic explanation for the alterations in the behavioral responses to neurosteroids of prenatally ethanol-exposed animals (44, 45). PS was shown to increase the number of ultrasonic vocalizations in pups subjected to maternal separation-induced stress (33), and this anxiogenic effect of PS was found to be reduced in pups from ethanol-exposed dams (33). We postulate that this decrease in the behavioral responses to exogenous PS could be due, in part, to alterations in the sensitivity of NMDA receptors to this neurosteroid in the hippocampus and other brain regions involved in the stress response. It would be important to determine if modulation of the stress response by endogenous neurosteroids is also altered by fetal ethanol exposure.

In conclusion, we found that prenatal exposure to ~0.08% blood alcohol levels does not produce detectable alterations in NMDA receptor function in neonatal hippocampal neurons after 6-7 days in culture. However, we found that exposure to ethanol in utero alters the actions of neurosteroids that positively modulate NMDA-R function and that this effect is not due to an alteration in the expression levels of NMDA-R subunits. A challenging task for future research will be to determine the mechanism and the precise contribution of these alterations to the pathophysiology of learning disabilities associated with fetal alcohol syndrome and alcohol-related neurodevelopmental disorders.


    ACKNOWLEDGEMENTS

We thank Rafael Galindo, Linda Beyer-Smith, and Alex De La Torre for assistance with rat breeding. We are also grateful to Drs. Bill Shuttleworth, Michael Wilson, and Don Partridge for advice and helpful discussions and to Rita A. Cardoso for technical assistance.


    FOOTNOTES

* This work was supported by National Institutes of Health Grants AA00227 (to C. F. V.) and AA06548 (to D. D. S.), Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil, Postdoctoral Fellowship 98/12714-6 (to E. T. C.), and a Research Resources grant from the Howard Hughes Medical Institute to the University of New Mexico School of Medicine.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Neurosciences, University of New Mexico Health Sciences Center, Basic Medical Sciences Building, Rm. 145, Albuquerque, NM 87131-5223. Tel.: 505-272-3128; Fax: 505-272-8082; E-mail: fvalenzuela@salud.unm.edu.

Published, JBC Papers in Press, September 14, 2000, DOI 10.1074/jbc.M004136200


    ABBREVIATIONS

The abbreviations used are: NMDA, N-methyl-D-aspartate; PS, pregnenolone sulfate, 5-pregnen-3beta -ol-20-one sulfate; PHS, pregnenolone hemisuccinate, 5-pregnen-3beta -ol-20-one hemisuccinate; 3alpha 5beta PS, 5beta -pregnan-3alpha -ol-20-one sulfate; 3alpha 5beta PHS, 5beta -pregnan-3alpha -ol-20-one hemisuccinate; ANOVA, analysis of variance; GABA, gamma -aminobutyric acid; R.U., relative units.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Larkby, C., and Day, N. (1997) Alcohol Health Res. World 21, 192-198
2. Streissguth, A. P., Bookstein, F. L., Sampson, P. D., and Barr, H. M. (1989) Neurotoxicol. Teratol. 11, 493-507
3. Mattson, S. N., Riley, E. P., Delis, D. C., Stern, C., and Jones, K. L. (1996) Alcohol Clin. Exp. Res. 20, 810-816
4. Uecker, A., and Nadel, L. (1996) Neuropsychologia 34, 209-223
5. Uecker, A., and Nadel, L. (1998) Am. J. Ment. Retard. 103, 12-18
6. Costa, E. T., Savage, D. D., and Valenzuela, C. F. (2000) Alcohol Clin. Exp. Res. 24, 706-715
7. Savage, D. D., Montano, C. Y., Otero, M. A., and Paxton, L. L. (1991) Alcohol 8, 193-201
8. Savage, D. D., Queen, S. A., Sanchez, C. F., Paxton, L. L., Mahoney, J. C., Goodlett, C. R., and West, J. R. (1992) Alcohol 9, 37-41
9. Diaz-Granados, J. L., Spuhler-Phillips, K., Lilliquist, M. W., Amsel, A., and Leslie, S. W. (1997) Alcohol Clin. Exp. Res. 21, 874-881
10. Abdollah, S., and Brien, J. F. (1995) Alcohol 12, 369-375 fgcg
11. Hughes, P. D., Kim, Y. N., Randall, P. K., and Leslie, S. W. (1998) Alcohol Clin. Exp. Res. 22, 1255-1261
12. Weaver, M. S., Lee, Y. H., Morris, J. L., Randall, P. K., Schallert, T., and Leslie, S. W. (1993) Alcohol Clin. Exp. Res. 17, 643-650
13. Lee, Y. H., Spuhler-Phillips, K., Randall, P. K., and Leslie, S. W. (1994) J. Pharmacol Exp. Ther. 271, 1291-1298
14. Spuhler-Phillips, K., Lee, Y. H., Hughes, P., Randoll, L., and Leslie, S. W. (1997) Alcohol Clin. Exp. Res. 21, 68-75
15. Gruol, D. L., Ryabinin, A. E., Parsons, K. L., Cole, M., Wilson, M. C., and Qiu, Z. (1998) Brain Res. 793, 12-20
16. Ebralidze, A. K., Rossi, D. J., Tonegawa, S., and Slater, N. T. (1996) J. Neurosci. 16, 5014-5025
17. Forrest, D., Yuzaki, M., Soares, H. D., Ng, L., Luk, D. C., Sheng, M., Stewart, C. L., Morgan, J. I., Connor, J. A., and Curran, T. (1994) Neuron 13, 325-338
18. Iwasato, T., Erzurumlu, R. S., Huerta, P. T., Chen, D. F., Sasaoka, T., Ulupinar, E., and Tonegawa, S. (1997) Neuron 19, 1201-1210
19. Kadotani, H., Hirano, T., Masugi, M., Nakamura, K., Nakao, K., Katsuki, M., and Nakanishi, S. (1996) J. Neurosci. 16, 7859-7867
20. Kishimoto, Y., Kawahara, S., Kirino, Y., Kadotani, H., Nakamura, Y., Ikeda, M., and Yoshioka, T. (1997) Neuroreport 8, 3717-3721
21. McHugh, T. J., Blum, K. I., Tsien, J. Z., Tonegawa, S., and Wilson, M. A. (1996) Cell 87, 1339-1349
22. Sprengel, R., Suchanek, B., Amico, C., Brusa, R., Burnashev, N., Rozov, A., Hvalby, O., Jensen, V., Paulsen, O., Andersen, P., Kim, J. J., Thompson, R. F., Sun, W., Webster, L. C., Grant, S. G., Eilers, J., Konnerth, A., Li, J., McNamara, J. O., and Seeburg, P. H. (1998) Cell 92, 279-289
23. Okabe, S., Collin, C., Auerbach, J. M., Meiri, N., Bengzon, J., Kennedy, M. B., Segal, M., and McKay, R. D. (1998) J. Neurosci. 18, 4177-4188
24. Bergeron, R., de Montigny, C., and Debonnel, G. (1996) J. Neurosci. 16, 1193-1202
25. Compagnone, N. A., and Mellon, S. H. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 4678-4683
26. Park-Chung, M., Wu, F. S., Purdy, R. H., Malayev, A. A., Gibbs, T. T., and Farb, D. H. (1997) Mol. Pharmacol. 52, 1113-1123
27. Wu, F. S., Gibbs, T. T., and Farb, D. H. (1991) Mol. Pharmacol. 40, 333-336
28. Yaghoubi, N., Malayev, A., Russek, S. J., Gibbs, T. T., and Farb, D. H. (1998) Brain Res. 803, 153-160
29. Flood, J. F., Morley, J. E., and Roberts, E. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10806-10810
30. Mathis, C., Paul, S. M., and Crawley, J. N. (1994) Psychopharmacol. Ser. (Berl) 116, 201-206
31. Mathis, C., Vogel, E., Cagniard, B., Criscuolo, F., and Ungerer, A. (1996) Neuropharmacology 35, 1057-1064
32. Vallee, M., Mayo, W., Darnaudery, M., Corpechot, C., Young, J., Koehl, M., Le Moal, M., Baulieu, E. E., Robel, P., and Simon, H. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 14865-14870
33. Zimmerberg, B., and McDonald, B. C. (1996) Pharmacol. Biochem. Behav. 55, 541-547
34. Allan, A. M., Wu, H., Paxton, L. L., and Savage, D. D. (1998) J. Pharmacol Exp. Ther. 284, 250-257
35. Lieber, C. S., and DeCarli, L. M. (1982) Alcohol Clin. Exp. Res. 6, 523-531
36. Majewska, M. D., and Schwartz, R. D. (1987) Brain Res. 404, 355-360
37. Rabow, L. E., Russek, S. J., and Farb, D. H. (1995) Synapse 21, 189-274
38. Morrisett, R. A., Martin, D., Wilson, W. A., Savage, D. D., and Swartzwelder, H. S. (1989) Alcohol 6, 415-420
39. Emptage, N., Bliss, T. V., and Fine, A. (1999) Neuron 22, 115-124
40. Calton, J. L., Kang, M. H., Wilson, W. A., and Moore, S. D. (2000) J. Neurophysiol. 83, 685-692
41. Irwin, R. P., Maragakis, N. J., Rogawski, M. A., Purdy, R. H., Farb, D. H., and Paul, S. M. (1992) Neurosci. Lett. 141, 30-34
42. ffrench-Mullen, J. M., Danks, P., and Spence, K. T. (1994) J. Neurosci. 14, 1963-1977
43. Fancsik, A., Linn, D. M., and Tasker, J. G. (2000) J. Neurosci. 20, 3067-3075
44. Zimmerberg, B., Brunelli, S. A., and Hofer, M. A. (1994) Pharmacol. Biochem. Behav. 47, 735-738
45. Zimmerberg, B., Drucker, P. C., and Weider, J. M. (1995) Pharmacol. Biochem. Behav. 51, 463-468


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
C. Dubois, M. Naassila, M. Daoust, and O. Pierrefiche
Early chronic ethanol exposure in rats disturbs respiratory network activity and increases sensitivity to ethanol
J. Physiol., October 1, 2006; 576(1): 297 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Mameli, M. Carta, L. D. Partridge, and C. F. Valenzuela
Neurosteroid-Induced Plasticity of Immature Synapses via Retrograde Modulation of Presynaptic NMDA Receptors
J. Neurosci., March 2, 2005; 25(9): 2285 - 2294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Meyer, M. Carta, L. D. Partridge, D. F. Covey, and C. F. Valenzuela
Neurosteroids Enhance Spontaneous Glutamate Release in Hippocampal Neurons. POSSIBLE ROLE OF METABOTROPIC sigma 1-LIKE RECEPTORS
J. Biol. Chem., August 2, 2002; 277(32): 28725 - 28732.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. D. C. Bailey, J. F. Brien, and J. N. Reynolds
Chronic Prenatal Ethanol Exposure Increases GABAA Receptor Subunit Protein Expression in the Adult Guinea Pig Cerebral Cortex
J. Neurosci., June 15, 2001; 21(12): 4381 - 4389.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/49/38268    most recent
M004136200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Costa, E. T.
Right arrow Articles by Valenzuela, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Costa, E. T.
Right arrow Articles by Valenzuela, C. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement